Global Health's Q3 FY 2025-26 Quarterly Results
- 05 Feb 2026
Result Summary
- Global Health Ltd reported a 2.1% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 19.1%.
- Its expenses for the quarter were up by 5.5% QoQ and 28.0% YoY.
- The net profit decreased 40.0% QoQ and decreased 33.5% YoY.
- The earnings per share (EPS) of Global Health Ltd stood at 3.54 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 1142.83 | 1118.95 | 959.46 | 2.1% | 19.1% |
Total Expenses | 986.45 | 935.12 | 770.40 | 5.5% | 28.0% |
Profit Before Tax | 119.78 | 199.81 | 189.07 | -40.1% | -36.6% |
Tax | 24.75 | 41.41 | 46.21 | -40.2% | -46.4% |
Profit After Tax | 95.03 | 158.40 | 142.86 | -40.0% | -33.5% |
Earnings Per Share | 3.54 | 5.89 | 5.32 | -39.9% | -33.5% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Global Health Ltd operates within the health sector, focusing on providing healthcare services. The company is known for its comprehensive range of medical services, which may include hospital management, patient care, and other health-related services. Although specific details on recent major developments are not provided in the available data, companies in this industry often engage in activities such as expanding their healthcare facilities, adopting new medical technologies, or entering partnerships to enhance service delivery. Global Health Ltd is likely involved in similar initiatives to maintain and grow its market presence.
Revenue
During the third quarter of the fiscal year 2026, Global Health Ltd reported a total income of ₹1,142.83 crores. This represents a quarter-over-quarter increase of 2.1% from ₹1,118.95 crores in the second quarter of the same fiscal year. Compared to the third quarter of the previous fiscal year (FY25), where total income was ₹959.46 crores, there is a notable year-over-year growth of 19.1%. This growth indicates a positive trajectory in revenue generation for the company over the past year.
Profitability
Global Health Ltd's profitability metrics for Q3FY26 indicate a decrease compared to the previous periods. The Profit Before Tax (PBT) for Q3FY26 is ₹119.78 crores, down 40.1% from ₹199.81 crores in Q2FY26 and 36.6% from ₹189.07 crores in Q3FY25. This decline is mirrored in the Profit After Tax (PAT), which stands at ₹95.03 crores for Q3FY26, reflecting a quarter-over-quarter decrease of 40.0% from ₹158.40 crores in Q2FY26 and a year-over-year decrease of 33.5% from ₹142.86 crores in Q3FY25. The Earnings Per Share (EPS) also follows this trend, with a Q3FY26 value of ₹3.54, down from ₹5.89 in Q2FY26 and ₹5.32 in Q3FY25.
Operating Metrics
The total expenses for Global Health Ltd in Q3FY26 amounted to ₹986.45 crores, showing a 5.5% increase from ₹935.12 crores in Q2FY26 and a significant 28.0% rise from ₹770.40 crores in Q3FY25. The tax expense for Q3FY26 is ₹24.75 crores, which decreased by 40.2% from ₹41.41 crores in Q2FY26 and by 46.4% from ₹46.21 crores in Q3FY25. These metrics provide insight into the company's cost management and tax strategy during the quarter. The increase in total expenses and the decrease in tax expenses are noteworthy operating metrics for this period.